D. R. Budman
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Genetics
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Larry NortonAnn D. ThorDonald A. BerryI. Craig HendersonGloria BroadwaterMaurice BarcosDaniel F. HayesEdison T. Liu
- Topics
- HER2/EGFR in Cancer Research (4 papers)Breast Cancer Treatment Studies (3 papers)Cancer therapeutics and mechanisms (2 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteBritish Journal of Cancer
- Partner nations
- United States
In The Last Decade
D. R. Budman
14 papers receiving 550 citations
Peers
Comparison fields: 5 of 70
- Oncology 272
- Molecular Biology 261
- Cancer Research 231
- Genetics 91
- Radiology, Nuclear Medicine and Imaging 84
Countries citing papers authored by D. R. Budman
This map shows the geographic impact of D. R. Budman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. R. Budman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. R. Budman more than expected).
Fields of papers citing papers by D. R. Budman
This network shows the impact of papers produced by D. R. Budman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. R. Budman. The network helps show where D. R. Budman may publish in the future.
Co-authorship network of co-authors of D. R. Budman
This figure shows the co-authorship network connecting the top 25 collaborators of D. R. Budman. A scholar is included among the top collaborators of D. R. Budman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. R. Budman. D. R. Budman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 122 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 82 | |
| 5 | 42 | |
| 6 | 146 | |
| 7 | 1 | |
| 8 | Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. | 63 |
| 9 | 31 | |
| 10 | Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours. | 34 |
| 11 | Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer. | 17 |
| 12 | Phase I trial of vinzolidine. | 7 |
| 13 | Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. | 4 |
| 14 | Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature. | 7 |
About D. R. Budman
D. R. Budman is a scholar working on Oncology, Cancer Research and Genetics, having authored 14 papers that have together received 562 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Cancer Research (231 citations), Oncology (272 citations) and Molecular Biology (261 citations). D. R. Budman has collaborated with scholars based in United States. Frequent co-authors include Larry Norton, Ann D. Thor, Donald A. Berry, I. Craig Henderson, Gloria Broadwater, Maurice Barcos, Daniel F. Hayes, Edison T. Liu, Willi Kreis and Lynn Dressler. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.